Use of electroporation to accelerate the skin permeability enhancing action of oleic acid

Biological and Pharmaceutical Bulletin

Volumn 23, Issue 7, 2000, Pages 850-854

  Takeuchi, Yoshikazu ^a   Miyawaki, Kohji ^a   Kamiyabu, Satoshi ^a   Fukushima, Shoji ^a   Yamaoka, Yumiko ^a   Kishimoto, Shuichi ^a   Taguchi, Kenji ^b   Masai, Hideki ^a   Kamata, Yuri ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Co application; Electroporation; Fourier transform attenuated total reflection spectroscopy; Oleic acid; Skin structural alteration

Indexed keywords

INDOMETACIN; OLEIC ACID;

ANIMAL TISSUE; ARTICLE; DRUG POTENTIATION; ELECTROPORATION; INFRARED SPECTROSCOPY; LIPID MEMBRANE; NONHUMAN; RAT; SKIN PERMEABILITY; STRATUM CORNEUM;

EID: 0033915244     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.23.850     Document Type: Article

References (24)

1. Weaver J. C., J. Cell. Biochem., 51, 426-435 (1993).
2. Plquett U., Langer R., Weaver J. C., Biochim. Biophys. Ada, 1239, 111-121 (1995).
3. Weaver J. C., Chizmadzhev Y. A., Bioelectrochem. Bioenerg., 41, 135-160 (1996).
4. Weaver J. C., Vaughan T. E., Chizmadzhev Y., JIDT Symposium Proceedings, 3, 143-147 (1998).
5. Chen T., Langer R., Weaver J. C., JID Symposium Proceedings, 3, 159-165 (1998).
6. Prausnitz M. R., Bose V. G., Langer R., Weaver J. C., Proc. Natl. Acad. Sci., U.S.A., 90, 10504-10508 (1993).
7. Vanbever R., Preat V., Bioelectrochem. Bioenerg., 38, 223-228 (1995).
8. Bhatia K. S., Singh J., Pharm. Res., 15, 1857-1862 (1998).
9. Vanbever R., Prausnitz M, R., Preat V., Pharm. Res., 14, 638-644 (1997).
10. Vanbever R., Leroy M., Preat V., J. Control Release, 54, 243-250 (1998).
11. Vanbever R., Morre N. D., Preat V., Pharm. Res., 13, 1360-1366 (1966).
12. Vanbever R., Langers G., Montmayeur S., Preat V., J. Control Release, 50, 225-235 (1998).
13. Preat A., Int. J. Pharm., 154, 229-234 (1997).
14. Wang S., Kara M., Krishnan T. R., J. Control Release, 50, 61-70 (1998).
15. Takeuchi Y., Yasukawa H., Yamaoka Y., Kato Y., Morimoto Y., Fukumori Y., Fukuda T., Chem. Pharm. Bull., 40, 1887-1892 (1992).
16. Takeuchi Y., Yamaoka Y., Fukushima S., Miyawaki K., Taguchi K., Yasukawa H., Kishimoto S., Suzuki M., Biol. Pharm. Bull., 21, 484-491 (1998).
17. Takeuchi Y., Yasukawa H., Yamaoka Y., Takahashi N., Tamura C., Morimoto Y., Fukushima S., Vasavada R. C., Chem. Pharm. Bull., 41, 1434-1437 (1993).
18. Golden G. M., Mackie J. E., Potts R. O., J. Pharm. Sci., 76, 25-28, (1987).
19. Golden G. M., Gusek D. B., Kennedy A. H., Mckie J. E., Potts R. O., Biochemistry, 26, 2382-2388 (1987).
20. Oertel R. P., Biopolymers, 16, 2329-2345 (1977).
21. Taguchi K., Takeuchi Y., Yamaoka Y., Fukushima S., Yasukawa H., Vasavada R. C., Suzuki M., J. Pharm. Sci., Technol. Jpn., 57, 65-73 (1997).
22. Levison K. K., Takayama K., Isowa K., Okabe K., Nagai T., J. Pharm. Sci., 83, 1367-1372 (1994).
23. Powell K. T., Morgenthaler A. W., Weaver J. C., Biophys. J., 56, 1163-1171 (1989).
24. Taguchi K., Fukushima S., Yamaoka Y., Kishimoto S., Takeuchi Y., Suzuki M., J. Pharm. Sci. Technol., Jpn., 59, 128-137 (1999).